All Releases
 |
BioForm Medical Reports Financial Results for Quarter Ended March 31, 2009, Third Quarter of Fiscal 2009
May 7, 2009
|
18.8 KB |
|
| |
SAN MATEO, Calif., May 7, 2009 (GlobeNewswire via COMTEX News Network) -- BioForm Medical, Inc. (Nasdaq:BFRM) today announced its financial results for the quarter ended March 31, 2009, which is the Company's third quarter of fiscal 2009. Net sales were $15.0 million for the quarter ended March 31, 2009 as compared to $17.0 million for the quarter ...
|
|
BioForm Medical to Announce Financial Results for Quarter Ended March 31, 2009 On May 7, 2009
Apr 16, 2009
|
9.1 KB |
|
| |
SAN MATEO, Calif., Apr 16, 2009 (GlobeNewswire via COMTEX News Network) -- BioForm Medical, Inc. (Nasdaq:BFRM) announced that on Thursday, May 7, 2009, it will report its financial results for the quarter ended March 31, 2009, which is its third quarter of fiscal year 2009. The Company will issue the earnings press release after the NASDAQ Global M...
|
|
BioForm Medical Strengthens Its Board of Directors With Three Aesthetics Industry Veterans
Mar 30, 2009
|
11.3 KB |
|
| |
Mar 30, 2009 (GlobeNewswire via COMTEX News Network) --
-- Chris Dennis, Former Global President of OrthoNeutrogena
-- Jeff Nugent, Former CEO of Revlon
-- Dennis Condon, President of BioForm Medical and Former
President of Mentor's Aesthetics Division
SAN MATEO, Calif., March 30, 2009 (GLOBE NEWSWIRE) -- BioForm Medical, I...
|
|
BioForm Medical to Launch New 1.5cc RADIESSE(r) Volume Advantage Syringe and 0.8cc RADIESSE Moderate Fill Syringe; Announces Successful Results of RADIESSE Dermal Filler With Lidocaine Clinical Study
Mar 6, 2009
|
12.3 KB |
|
| |
SAN MATEO, Calif., Mar 6, 2009 (GlobeNewswire via COMTEX News Network) -- BioForm Medical, Inc. (Nasdaq:BFRM) today announced two new product forms of RADIESSE(r) dermal filler - the 1.5cc RADIESSE Volume Advantage syringe and the 0.8cc RADIESSE Moderate Fill syringe - which will be introduced at the American Academy of Dermatology's (AAD) 67th Ann...
|
|
BioForm Medical Reports Financial Results for Quarter Ended December 31, 2008, Second Quarter of Fiscal 2009
Feb 5, 2009
|
18.9 KB |
|
| |
SAN MATEO, Calif., Feb 5, 2009 (GlobeNewswire via COMTEX News Network) -- BioForm Medical, Inc. (Nasdaq:BFRM) today announced its financial results for the quarter ended December 31, 2008, which is the Company's second quarter of fiscal 2009. Net sales were $16.7 million for the quarter ended December 31, 2008 as compared to $18.6 million for the q...
|
|
BioForm Medical to Announce Financial Results for the Quarter Ended December 31, 2008 On February 5, 2009
Jan 21, 2009
|
9.4 KB |
|
| |
SAN MATEO, Calif., Jan 21, 2009 (GlobeNewswire via COMTEX News Network) -- BioForm Medical, Inc. (Nasdaq:BFRM) announced that on Thursday, February 5, 2009, it will report its financial results for the quarter ended December 31, 2008, which is its second quarter of fiscal year 2009. The Company will issue the earnings press release after the NASDAQ...
|
|
One Million Syringes of RADIESSE(r) Dermal Filler Have Been Shipped
Jan 8, 2009
|
14.2 KB |
|
| |
SAN MATEO, Calif. and PARIS, Jan 8, 2009 (GlobeNewswire via COMTEX News Network) -- BioForm Medical, Inc. (Nasdaq:BFRM) today announced, at a presentation at the 11th Annual Meeting of the International Master Course on Aging Skin (IMCAS), that it has shipped more than 1,000,000 syringes of RADIESSE(r) dermal filler worldwide since 2002. RADIESSE d...
|
|
BioForm Medical Announces Participation At Two Upcoming Investor Events
Dec 5, 2008
|
9.2 KB |
|
| |
Dec 5, 2008 (GlobeNewswire via COMTEX News Network) --
RBC Capital Markets 2008 Healthcare Conference on December 10, 2008
J.P. Morgan 27th Annual Healthcare Conference on January 15, 2009
SAN MATEO, Calif., Dec. 5, 2008 (GLOBE NEWSWIRE) -- BioForm Medical, Inc. (Nasdaq:BFRM) announced today that the Company will participate at...
|
|
BioForm Medical Reports Financial Results for Quarter Ended September 30, 2008, First Quarter of Fiscal 2009
Nov 6, 2008
|
19.4 KB |
|
| |
SAN MATEO, Calif., Nov 6, 2008 (GlobeNewswire via COMTEX News Network) -- BioForm Medical, Inc. (Nasdaq:BFRM) today announced its financial results for the quarter ended September 30, 2008, which is the Company's first quarter of fiscal 2009. Net sales were $15.7 million for the quarter ended September 30, 2008 as compared to $15.2 million for the ...
|
|
BioForm Medical Announces Earnings Call On November 6, 2008, and Presentations At Two Healthcare Investor Conferences
Oct 27, 2008
|
9.5 KB |
|
| |
Oct 27, 2008 (GlobeNewswire via COMTEX News Network) --
First Quarter Fiscal 2009 financial results conference call on
November 6, 2008
Presentation at Oppenheimer's 19th Annual Healthcare Conference on
November 3, 2008
Presentation at 20th Annual Piper Jaffray Health Care Conf...
|
|
BioForm Medical to Present at the 2008 Maxim Group Growth Conference
Oct 1, 2008
|
9.3 KB |
|
| |
SAN MATEO, Calif., Oct 01, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) announced today that it is scheduled to present at the 2008 Maxim Group Growth Conference on Tuesday, October 7, 2008. Derek Bertocci, Chief Financial Officer of BioForm Medical, is scheduled to provide a corporate overview of the ...
|
|
BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008
Sep 4, 2008
|
19.1 KB |
|
| |
SAN MATEO, Calif., Sept 04, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced its financial results for the fourth quarter and full fiscal year ended June 30, 2008. Net sales were $16.7 million for the quarter ended June 30, 2008 as compared to $15.4 million for the quarter ended June 30, 20...
|
|
338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment
Sep 4, 2008
|
12.9 KB |
|
| |
SAN MATEO, Calif., Sept 04, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced that the pivotal clinical study of Polidocanol, conducted in Germany by BioForm Medical's partner, Chemische Fabrik KREUSSLER & Co. GmbH (Kreussler), successfully met the study primary endpoint and has been submitt...
|
|
BioForm Medical to Announce Financial Results for Quarter and Fiscal Year Ended June 30, 2008, and Host Conference Call and Webcast on September 4, 2008
Aug 22, 2008
|
9.4 KB |
|
| |
SAN MATEO, Calif., Aug 22, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) announced that on Thursday, September 4, 2008, it will report its financial results for its fourth quarter and fiscal year ended June 30, 2008. The Company will issue the earnings press release after the NASDAQ Global Market closes...
|
|
Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic Surgery Special Issue on Fillers
Jun 26, 2008
|
17.1 KB |
|
| |
SAN MATEO, Calif., June 26, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced the publication of five studies in the June 2008 issue of the Journal of Dermatologic Surgery, a peer-reviewed publication of the American Society of Dermatologic Surgery. The five published clinical and preclinica...
|
|
BioForm Medical to Present at the 2008 Jefferies Second Annual Healthcare Conference
Jun 20, 2008
|
9.3 KB |
|
| |
SAN MATEO, Calif., June 20, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced that Steven Basta, Chief Executive Officer of BioForm Medical will present a company overview at the upcoming Jefferies Second Annual Healthcare Conference being held June 24-26th, 2008 in New York. BioForm Medical...
|
|
CryoLife's BioGlue® Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery
Jun 10, 2008
|
12.0 KB |
|
| |
ATLANTA and SAN MATEO, Calif., June 10, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- CryoLife, Inc. (NYSE: CRY), and BioForm Medical, Inc. (Nasdaq: BFRM) today announced that they have received a CE Mark for the use of CryoLife's BioGlue Surgical Adhesive for periosteal fixation following endoscopic browplasty or brow lift, a reconstructi...
|
|
BioForm Medical Announces Extension of Lock-Up Period
May 5, 2008
|
8.8 KB |
|
| |
SAN MATEO, Calif., May 5, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) announced today that lock-up agreements entered into with its underwriters in conjunction with its initial public offering will be extended 18 days beyond the Company's May 1, 2008 earnings release. The lock-up period was due to exp...
|
|
BioForm Announces Financial Results for Quarter Ended March 31, 2008, Third Quarter of Fiscal 2008
May 1, 2008
|
16.5 KB |
|
| |
SAN MATEO, Calif., May 1, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced its financial results for the quarter ended March 31, 2008, which is the Company's third quarter of fiscal year 2008. Net sales were $17.0 million for the quarter ended March 31, 2008 as compared to $12.4 million for...
|
|
BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology
Apr 30, 2008
|
13.1 KB |
|
| |
SAN MATEO, Calif., April 30, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- BioForm Medical, Inc. (Nasdaq: BFRM) announced that it has acquired substantially all of the assets of privately-held, Denver, CO based, Advanced Cosmetic Intervention, Inc. (ACI) and associated technology rights for $12 million cash, plus future royalties and a pot...
|
|
|
